Patients Are the Co-Designer — Plexāā’s Gaele Lalahy
Why It Matters
Embedding patients in every design decision accelerates adoption, improves outcomes, and positions medtech firms for sustainable growth.
Key Takeaways
- •Plexa mandates patient approval for every product decision
- •Patient-as-co‑designer model drives Bloom device development through continuous feedback
- •Gail’s consumer‑tech background fuels cross‑industry competitive mindset for innovation
- •Device Talks conferences showcase collaborative, patient‑focused medtech leadership
- •Early‑stage leaders benefit from diverse experiences beyond traditional medtech
Summary
The Women in MedTech podcast episode features Gail Lalahy, COO of Plexa, discussing the company's 'patient as co‑designer' philosophy behind its Bloom device and how that approach reshapes product development.
Plexa has institutionalized a rule that no decision proceeds without patient input, turning feedback loops into a core governance tool. Gail draws on her consumer‑technology background to push the Bloom platform toward faster, user‑centric iterations, while also emphasizing a competitive mindset that aims to make medtech excel alongside larger industries.
Key moments include Gail's statement, 'no decision will be made unless it's run by a patient,' and her anecdote about competing as a national rhythmic gymnast, illustrating how creative problem‑solving from sports informs her leadership style. She also declares, 'I don't just want to be the best at making a medical device; I want to be the best across all industries.'
The patient‑co‑design model signals a broader industry shift toward transparency and user empowerment, promising better clinical outcomes, stronger investor confidence, and a more attractive career path for new talent. As devices become smarter and more connected, integrating patients early could become a competitive differentiator.
Comments
Want to join the conversation?
Loading comments...